Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Jeroen J. Bax
The session provided both an update on the current status of percutaneous valve therapy, as well as a summary on the utilization of imaging modalities in patient selection for these therapies. Dr. Vahanian from France provided an excellent overview on the current status of percutaneous mitral valve therapy. The techniques are rapidly developing and are focused on percutaneous repair and replacement of the mitral valve. Specifically in severe heart failure patients, therapeutic options for mitral regurgitation are limited and percutaneous repair with the mitraclip procedure may provide a valuable option. The second lecture was provided by Dr. Erbel from Germany, and the topic was the current status of percutaneous aortic valve therapy. The large trials that were recently published were summarized, and a large European registry was presented. Clearly, this therapy is more and more implemented in the clinical routine. Importantly, Dr. Erbel indicated that specific guidelines are needed to determine the precise target population; in the perspective, it is worth mentioning that ESC will issue the new valve guidelines in 2012. The last 2 lectures were provided by Dr. Tuzcu from the United States, who carefully evaluated the role of the different imaging techniques in percutaneous valve therapy. It has become evident that imaging is needed in patient selection, but also during the procedure and at systematic predefined follow-up moments. Cardiac CT is extremely useful in patient selection, both for percutaneous mitral valve and aortic valve therapy. This technique provides the best anatomic information; a good alternative is provided by MRI. Echocardiography (particularly 3D echo) is used during prior to and during the procedure. Finally, fluoroscopy is needed during the procedures. The conclusion from these 2 lectures by Dr. Tuzcu was that an excellent collaboration between invasive and non-invasive cardiologists is needed.
Imaging in percutaneous valve therapy
© 2017 European Society of Cardiology. All rights reserved